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Abstract
Cryptococcus neoformans is an opportunistic fungal pathogen that causes serious human disease in immunocompromised
populations. Its polysaccharide capsule is a key virulence factor which is regulated in response to growth conditions,
becoming enlarged in the context of infection. We used microarray analysis of cells stimulated to form capsule over a range
of growth conditions to identify a transcriptional signature associated with capsule enlargement. The signature contains
880 genes, is enriched for genes encoding known capsule regulators, and includes many uncharacterized sequences. One
uncharacterized sequence encodes a novel regulator of capsule and of fungal virulence. This factor is a homolog of the
yeast protein Ada2, a member of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) complex that regulates transcription of stress
response genes via histone acetylation. Consistent with this homology, the C. neoformans null mutant exhibits reduced
histone H3 lysine 9 acetylation. It is also defective in response to a variety of stress conditions, demonstrating phenotypes
that overlap with, but are not identical to, those of other fungi with altered SAGA complexes. The mutant also exhibits
significant defects in sexual development and virulence. To establish the role of Ada2 in the broader network of capsule
regulation we performed RNA-Seq on strains lacking either Ada2 or one of two other capsule regulators: Cir1 and Nrg1.
Analysis of the results suggested that Ada2 functions downstream of both Cir1 and Nrg1 via components of the high
osmolarity glycerol (HOG) pathway. To identify direct targets of Ada2, we performed ChIP-Seq analysis of histone
acetylation in the Ada2 null mutant. These studies supported the role of Ada2 in the direct regulation of capsule and mating
responses and suggested that it may also play a direct role in regulating capsule-independent antiphagocytic virulence
factors. These results validate our experimental approach to dissecting capsule regulation and provide multiple targets for
future investigation.
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Introduction
Cryptococcus neoformans is an opportunistic fungal pathogen [1].
The disease it causes, cryptococcosis, is contracted by inhalation of
infectious particles (spores [2] or dessicated cells), which initiate a
pulmonary infection. In the setting of immune compromise the
fungus disseminates, with particular predilection for the central
nervous system where it can cause a fatal meningoencephalitis. In
otherwise healthy hosts, the infection may remain latent for
extended periods, emerging in the event of immune compromise
[3]. The impact of the disease is significant, especially in
populations with limited access to health care, leading to an
estimated 600,000 deaths per year [4].
A variety of factors have been implicated in cryptococcal
virulence. These include melanin synthesis [5]; urease and
phospholipase secretion [6,7]; titan cell formation [8,9]; and the
ability to survive at host body temperature. Additionally, the main
feature that distinguishes C. neoformans from other pathogenic fungi
is an extensive polysaccharide capsule that surrounds the cell wall
and is required for virulence [10]. Capsule size varies tremen-
dously with growth conditions, becoming particularly large during
mammalian infection [11]. Capsule expansion can be induced in
vitro by mimicking aspects of the host environment such as low iron
availability, the presence of mammalian serum, and physiological
concentrations of carbon dioxide [12–14]. Strain virulence
correlates with capsule size in vivo [15], implicating the regulation
of capsule formation as a critical factor in the pathophysiology of
cryptococcal disease.
Our current knowledge of capsule regulation derives primarily
from studies where mutations of specific genes yield cells with
abnormal capsules. A variety of readily assayed phenotypes that
are related to the size or nature of the capsule (including cell
sedimentation behavior [16], antibody reactivity [17], India ink
staining, and colony morphology) has enabled the identification of
a wide array of such mutants. Most of these have reduced
virulence, emphasizing the central role of the cryptococcal capsule
in pathogenesis.
Capsule size is regulated by distinct and overlapping signaling
pathways, including those typically associated with stress response.
The best-characterized of these, the cAMP pathway, responds to
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[18]. Stimulation of this pathway leads to high intracellular cAMP
levels, which activate the kinase Pka1 [19]. This enzyme in turn
activates the C2H2 zinc finger transcription factor Nrg1, leading to
the transcriptional induction of genes that are directly involved in
capsule assembly [20]. Pka1 also activates another transcription
factor, Rim101, which is necessary for capsule enlargement.
Interestingly, activation of Rim101 requires elements of both the
cAMP pathway and the pH-responsive Rim signaling pathway
[21]. Deletion of the genes encoding Pka1, Nrg1, or Rim101 leads
to reduced capsule size.
Iron sensing mechanisms also influence capsule formation.
Transcription factors Hap3 and Hap5 are involved in both iron
homeostasis and capsule regulation; deletion of the corresponding
genes leads to a reduction in capsule size [22]. In addition to
Hap3 and Hap5, the iron responsive transcription factor Cir1
also regulates capsule [23], in part by transcriptionally regulating
the cAMP pathway. Recently, ChIP-chip studies revealed that
Cir1 is directly regulated by another transcription factor, Gat201
[24]. Strains lacking either Cir1 [23] or Gat201 are hypocapsular
[25].
Capsule regulation is also influenced by the HOG pathway.
Several proteins in this pathway (including Hog1, Pbs2, and Ssk2)
negatively regulate capsule size [26]. Epistasis analysis shows that
the cAMP pathway is required for this HOG-dependent influence
on capsule, but the mechanism of the cross-talk between these two
central signaling pathways is unknown. Normal capsule formation
also requires proteins in pathways related to temperature sensing
[27], sexual development [28], and cell wall integrity [29,30].
More broadly, chromatin remodeling has been implicated in
capsule regulation, by the observation that cells lacking the histone
acetyltransferase Gcn5 are hypocapsular [31]. Gcn5 is a member
of the well-conserved SAGA complex, which acts in transcrip-
tional regulation from fungi to humans [32]. Sequence analysis
suggests that other SAGA proteins are present in C. neoformans, but
Gcn5 is the best conserved and the only one that has been
characterized [31].
Over 60 genes have been identified as important players in
capsule formation due to the effects of their deletion on capsule
structure or morphology; we refer to such genes as ‘capsule-
implicated’ (Table S1). However, because the majority of
cryptococcal transcription factors and signaling proteins are
uncharacterized, it is likely that important elements of the capsule
regulatory network are missing from this group. Furthermore,
some capsule-implicated genes may be required for other primary
functions, such as cell wall synthesis, that have incidental effects on
capsule formation.
As reviewed above, components of several known signaling
pathways are required for capsule formation, but there is no model
that accounts for the integration of these pathways to regulate
capsule growth. To begin constructing such a model, we have
identified genes whose RNA levels are correlated with capsule size
over a range of in vitro conditions. We term this set of genes the
transcriptional signature of capsule. This signature includes
previously capsule-implicated genes as well as multiple unchar-
acterized genes encoding putative regulatory factors. We chose to
analyze one uncharacterized gene, ADA2, which encodes a
putative DNA-binding protein. We now show that Ada2 is a
novel regulator of capsule and of other virulence-related features
of Cryptococcus. Analysis of downstream targets of Ada2 and
other capsule regulators by RNA-Seq and ChIP-Seq suggests the
context of Ada2 in the capsule regulatory network and illustrates
the effectiveness of this approach in unraveling complex regulatory
networks.
Results
Identifying the Transcriptional Signature of Capsule
We reasoned that the transcript abundance of many genes
involved in the regulation and synthesis of capsule would correlate
with capsule size across multiple growth conditions. To test this
hypothesis, and potentially identify capsule regulatory genes beyond
those previously reported, we cultured the C. neoformans serotype A
reference strain H99 in four conditions known to stimulate capsule
formation to varying degrees. For each condition, we also cultured
the cells in a similar medium that stimulates capsule formation to a
lesser extent. The eight conditions used were low iron medium
(LIM) with and without the chelating agent ethylenediaminetetra-
acetic acid (EDTA); phosphate-buffered saline (PBS) with and
without fetal bovine serum (FBS); Dulbecco’s Modified Eagle’s
Medium (DMEM) in room air (RA) or in 5% CO2; and Littman’s
medium (LIT) with two concentrations of thiamine (LO-THI /
HI-THI). After 24 h the average capsule radius in each culture
was assessed by light microscopy. The remaining cells were used
to isolate total RNA for hybridization against a C. neoformans sero-
type A/D microarray (http://gtac.wustl.edu/services/microarray/
rna-analysis/cryptococcus-neoformans.php). To identify genes
whose transcript abundance correlated with capsule size, we
compared the transcription profiles over all eight conditions to the
quantitative measurements of capsule radius (Figure 1).
Our analysis revealed 880 genes whose transcript abundance
correlated significantly with capsule size (Table S2), which we
considered the transcriptional signature of capsule induction.
Within this set, we identified 316 genes whose transcription
correlated positively with capsule radius and 564 genes whose
transcription correlated negatively. Among the positively
correlated genes, most are involved in responses to stress,
including DNA damage repair, trehalose biosynthesis and
sugar transport. In contrast, many of the negatively correlated
genes are involved in mitochondrial function and ribosome
biogenesis.
Author Summary
Cryptococcus neoformans is a fungal pathogen that causes
serious disease in immunocompromised individuals, killing
over 600,000 people per year worldwide. A major factor in
the ability of this microbe to cause disease is an extensive
polysaccharide capsule that surrounds the cell and
interferes with the host immune response to infection.
This capsule expands dramatically in certain growth
conditions, including those found in the mammalian host.
We grew cells in multiple conditions and assessed gene
expression and capsule size. This allowed us to identify a
‘transcriptional signature’ of genes whose expression
correlates with capsule size; we speculated that a subset
of these genes acts in capsule regulation. To test this
hypothesis, we characterized one previously unstudied
gene in this signature and found it to be a novel regulator
of capsule expansion, fungal virulence, and mating. This
gene encodes cryptococcal Ada2, a well-conserved protein
that regulates genes involved in stress response and
development. We used phenotypic analysis, RNA sequenc-
ing, and chromatin-immunoprecipitation sequencing
(ChIP-Seq) to situate Ada2 in the complex network of
genes that regulate capsule and other cryptococcal
virulence factors. This approach, which yielded insights
into the regulation of a critical fungal virulence factor, is
applicable to similar questions in other pathogens.
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signature would specifically influence the formation of capsule (see
Discussion). Consistent with this hypothesis, the set of genes whose
RNA levels correlated positively with capsule size was enriched for
capsule-implicated genes (p , 0.02; see Methods); no such
enrichment was observed among genes that correlated negatively.
Positively correlated genes that are capsule-implicated included
the genes encoding regulatory proteins Cir1, Hap5 [22], and
Ste20 [33] and the phosphodiesterases Pde1 and Pde2 [34] (see
Discussion).
The transcriptional signature of capsule included previously
uncharacterized genes that encode putative transcription factors,
signaling proteins, and sugar transporters (Table S2). It is likely
that many of these genes are involved in capsule regulation and
assembly. We were particularly interested in one previously
uncharacterized gene, CNAG_01626, which encodes a putative
DNA binding protein. Expression of CNAG_01626 correlated
positively with capsule size (Figure 2). For comparison, Figure 2
also shows the correlations obtained for two cryptococcal
transcriptional regulators, CIR1 and SSN801, whose roles in
capsule regulation have previously been demonstrated. CIR1
showed significant positive correlation with capsule size, consistent
with the hypocapsular phenotype of cir1D mutants [23], while
SSN801 exhibited a negative correlation with capsule size,
consistent with the hypercapsular phenotype of the corresponding
deletion mutant [25].
Given the strong correlation of CNAG_01626 transcription
with capsule size, we suspected that the corresponding gene
product was a regulator of capsule formation. Because this gene
encodes multiple putative DNA-binding domains (Myb-like and
SWIRM), we further expected that it might act at a transcriptional
level. This hypothesis was supported by the 33% homology we
noted between the amino acid sequence predicted for
CNAG_01626 and that of the Saccharomyces cerevisiae Ada2 protein.
In S. cerevisiae, Ada2 is a member of the Spt-Ada-Gcn5
Figure 1. The transcriptional signature of capsule induction.
Shown is a heat map of gene expression (blue, low expression; yellow,
high expression) for the 880 genes whose expression, as assessed by
microarray analysis, trends with capsule size. Cell growth conditions
(see Methods) for each column are indicated below the heat map (see
Results for abbreviations) and average capsule radius is plotted above
(gray bars). The correlation of gene expression and capsule size is
plotted at the right.
doi:10.1371/journal.ppat.1002411.g001
Figure 2. Correlation of gene expression and capsule size for
selected genes. Data is shown for three genes that demonstrate
correlation between gene expression and capsule size.
doi:10.1371/journal.ppat.1002411.g002
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tion [35]. Within SAGA, Ada2 is required for proper catalytic
activity of the acetyltransferase Gcn5 [36]. Based on the homology
between the cryptococcal gene and S. cerevisiae ADA2, we decided
to refer to CNAG_01626 as ADA2.
Cryptococcal Ada2 Influences Capsule Formation
Since transcription of the cryptococcal ADA2 gene positively
correlates with capsule size, we hypothesized that deleting ADA2
would yield hypocapsular cells. To assess the role of this putative
transcriptional regulator in capsule formation, we replaced the
ADA2 genomic coding sequence with a nourseothricin-resistance
marker (NAT) in the serotype A strain KN99a, derived from the
serotype A reference strain H99 [37]. We then incubated ada2D
mutant cells under capsule-inducing conditions and examined
capsule size by negative staining with India ink. Consistent with
the microarray analysis (Figure 2), ada2D mutant cells had
dramatically reduced capsule compared to wild type (Figure 3).
This phenotype was reversed by complementation with the ADA2
genomic coding sequence (ada2D::ADA2 in Table S3; see
Methods).
To facilitate comparison of ada2D to strains lacking other capsule
regulators, we also deleted CIR1, NRG1, and SSN801 in KN99a (see
Methods). Consistent with earlier reports, the ssn801D capsule was
enlarged, while the cir1D and nrg1D capsules were reduced, similar
to the capsule produced by ada2D (Figure 3, panel A).
Cryptococcal Ada2 Is Localized to the Nucleus and Is
Involved in Histone Acetylation
Having demonstrated that cryptococcal Ada2 influences capsule
expansion, we proceeded to further investigate its role. Given the
function of the SAGA complex in histone acetylation in S. cerevisiae
[35], we expected that cryptococcal Ada2 would reside in the
nucleus. To test our hypothesis, we integrated a hemagglutinin
(HA) epitope-tag sequence at the 39 end of the ADA2 genomic
coding sequence and examined the localization of the tagged
protein (Ada2-HA) by immunofluorescence microscopy. Consis-
tent with the nuclear role of Ada2 in S. cerevisiae, the tagged
cryptococcal protein colocalizes with nuclear DNA (Figure 4).
In S. cerevisiae, the SAGA complex activates transcription of
stress-responsive genes by acetylating specific lysine residues at the
N-terminal tails of histones H2B and H3 [35,38]. One of these
modifications is the acetylation of lysine 9 of histone H3 (H3K9).
To assess whether Ada2 is involved in similar histone acetylation
in C. neoformans, we analyzed the abundance of acetylated H3K9 in
the ada2D mutant by immunofluorescence microscopy using an
antibody specific for this modification. We found that the
fluorescence intensity of mutant cell nuclei was reduced by at
least 50% compared to nuclei of both wild type and complement-
ed cells (Figure 5), a result we confirmed on the population level by
immunoblotting with the same antibody (not shown). In contrast,
H4 acetylation, which is not SAGA specific [39,40], showed no
difference between the ada2D mutant and either the wild type or
complemented strains (not shown). These results demonstrate the
role of CNAG_01626 in histone acetylation, likely in the context
of C. neoformans SAGA, and strongly support our identification of
this novel capsule regulator as the cryptococcal homolog of the S.
cerevisiae ADA2.
Ada2 Functions in a Subset of Stress Response Pathways
and in Mating
In S. cerevisiae and other fungi, the SAGA complex regulates the
response to stress conditions such as elevated temperature, high
salt concentration, and oxidative damage [41,42]. We found that
the ada2D mutant grew normally compared to wild type on rich
medium (YPD) at 30uC (Figure 6). However, the mutant exhibited
a subtle growth impairment at 37uC, and a moderate attenuation
of growth at 39uC. In all cases, the complemented strain behaved
like wild type (Figure 6).
To further compare the phenotype of ada2D to known fungal
SAGA mutants, we next tested a panel of stress conditions for their
effect on growth of the wild type, mutant, and complemented
strains at both 30 and 37uC (Figure 6). We found that mutant cells
were highly sensitive to alkaline pH, with no growth at pH 8.8 at
37uC, while growth at physiological or acidic (5.5) pH was like that
of wild type (not shown). Growth of ada2D at 37uC was also
abolished when 6% ethanol was included in the medium, in
notable contrast to the growth of wild type cells under this
condition, and was impaired at 0.4 M CaCl2. Conditions that
challenge cell integrity, including media containing calcofluor
white (0.2%), congo red (0.5%), low levels of SDS (0.01%), or high
Figure 3. Cells lacking ADA2 display reduced capsule size under
inducing conditions. Panel A, negative staining with India ink of
KN99a cells (WT), the indicated deletion strains, and the complemented
ada2D mutant (ADA2). All images are at the same magnification. Scale
bar, 5 mm. Panel B, histogram of capsule size for the ada2D mutant (red)
and WT (black) populations. Capsule radius is represented in microns.
doi:10.1371/journal.ppat.1002411.g003
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Similarly, KCl (1.2 M) and NaCl (0.4 M) did not alter growth (not
shown), although high NaCl concentrations (1.2 M) did reduce
growth at 37uC compared to wild type (Figure 6). The ada2D
mutant also showed enhanced growth on caffeine and LiCl at
30uC, although this difference was not observed at the higher
temperature tested (see Discussion).
The ability of C. neoformans to withstand nitrosative and
oxidative stress is required for the virulence of this yeast [43,44].
We therefore tested the effect of Ada2 absence on cryptococcal
sensitivity to compounds that induce such stress. Growth of the
ada2D mutant was not affected by NaNO2 (0.5 mM) at 30uC but
exhibited a significant defect at 37uC. The mutant was highly
sensitive to oxidative stress (0.5 mM H2O2), with growth
attenuated at 30uC and absent at 37uC. (Figure 6). We also
examined the ability of this mutant to produce melanin, a feature
of C. neoformans that is associated with virulence [5]. We observed
no difference in melanin production on medium containing L-3,4-
dihydroxyphenylalanine (L-DOPA; not shown).
Finally, we tested the sensitivity of the ada2D strain to several
pharmacological agents. These included fluconazole, amphoteri-
cin B, and flucytosine, all antifungal compounds used to treat
cryptococcal infections. Growth in all cases was comparable to
that of wild type, in contrast to the increased fluconazole sensitivity
observed upon deletion of ADA2 in Candida albicans [40]. We also
tested the sensitivity of ada2D to FK506, a compound that inhibits
calcineurin signaling. A C. neoformans gcn5D strain has been shown
to be FK506 sensitive, suggesting a defect in this pathway [31] (see
Discussion); ada2D cells were even more sensitive to this compound
(data not shown).
While back-crossing the ada2D mutant, we noticed that this
strain was slow to filament. To investigate the potential role of
Ada2 in cryptococcal sexual development, we crossed mating type
a and a cells bearing the ada2D mutation to KN99a and KN99a
Figure 5. Histone acetylation is markedly reduced in the
absence of Ada2. Shown are immunofluorescence micrographs of
wild type (WT), ada2D, and complemented ada2D (ADA2) cells grown in
capsule inducing conditions for 90 min and then probed with antibody
to H3K9 (aH3-K9). All images were acquired at the same settings and
are shown at the same magnification; scale bar, 1 mm.
doi:10.1371/journal.ppat.1002411.g005
Figure 6. Ada2 is required for growth under certain stress
conditions. Ten-fold serial dilutions of the indicated strains were
grown in the conditions shown (see Methods for details). Top panel,
growth on rich medium (YPD) at the temperatures indicated above the
images; middle panels (four rows of images), growth on YPD with the
indicated stressor at the temperatures shown at the right; bottom panel
(two rows of images), growth on minimal medium (YNB) or YNB with
the indicated stressor at the temperatures shown at the right.
doi:10.1371/journal.ppat.1002411.g006
Figure 4. Cryptococcal Ada2 is localized to the nucleus. Wild
type cells (WT) and cells modified to express HA epitope-tagged Ada2
from the native locus (ADA2-HA) were labeled with an antibody against
HA (aHA, red), and counter-stained with DAPI (blue) to show the
location of chromatin. All images were acquired at the same settings
and are shown at the same magnification. Scale bar, 1 mm.
doi:10.1371/journal.ppat.1002411.g004
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mating type dramatically impaired the formation of dikaryotic
filaments in unilateral crosses between the mutant and wild type. A
bilateral cross between two ada2D mutants of opposite mating type
showed no visible hyphal development even after 13 days, while
the complemented strain behaved identically to wild type.
Cryptococcal Ada2 is Essential for C. neoformans
Virulence
The ada2D mutant displays a smaller capsule, demonstrates
reduced resistance to oxidative and nitrosative stress, and grows
more slowly at 37uC compared to wild type. Based on these
characteristics, we hypothesized that the mutant would also be
attenuated for virulence. Indeed, we found that pulmonary growth
of the ada2D mutant was impaired by almost 100-fold compared to
the wild type and complemented strains in an inhalational mouse
model of cryptococcosis (Figure 8, panel A), although it did grow
slightly better than a completely acapsular mutant (cap59D). To
pursue this observation, we conducted a survival study with the
same four strains. By three weeks post-inoculation, all mice
infected with the wild type and complemented strains had
succumbed to the infection (Figure 8, panel B). In contrast, mice
infected with the ada2D or cap59D mutants remained healthy
throughout the study, confirming the requirement for Ada2 in the
virulence of this yeast.
Cryptococcal Ada2 Transcriptionally Regulates Genes
Required for Host Adaptation
To identify the genes and processes regulated by Ada2, we used
RNA-Seq to perform transcriptome analysis of the ada2D mutant
and wild type cells cultured in either capsule-inducing or capsule
non-inducing conditions (see Methods). The majority (92%) of the
resulting short reads mapped to the C. neoformans serotype A
reference sequence [45], indicating the excellent quality of the
data. The average 300-fold coverage of the cryptococcal
transcripts we obtained in these studies allowed confident sequence
identification, and will help improve annotation of the C. neoformans
genome.
Gene expression analysis revealed 460 genes that were
differentially expressed in the ada2D mutant compared to wild
type under the capsule inducing condition; 675 genes were
differentially expressed between the two strains under the capsule
non-inducing condition (Table S4). We examined the genes whose
expression was significantly affected in one or both conditions.
Most of these (73%) were regulated in a sign consistent manner in
the two conditions (e.g. if gene expression was reduced in the ada2D
mutant in non-inducing conditions it was also reduced in the
mutant in inducing conditions), although the magnitude of
changes did vary. Gene ontology (GO) analysis (see Methods)
indicated that processes significantly enriched in the response to
loss of Ada2 included ribosomal protein synthesis, sugar transport,
and carbohydrate metabolism.
Consistent with the filamentation defect we observed in the
ada2D mutant (Figure 7), we noted several genes downstream of
Ada2 that are involved in cryptococcal sexual development
(Table 1). Two mating type-specific genes (encoding the
Figure 7. Ada2 is required for normal hyphal development.
Wild type (no strain designation), ada2D, and complemented ada2D
(ADA2) strains of opposite mating type were mixed and grown under
conditions that induce mating (see Methods). Patches were imaged
after 13 days.
doi:10.1371/journal.ppat.1002411.g007
Figure 8. Ada2 is required for growth and virulence in mice.
Panel A, C57Bl/6 mice were intranasally inoculated with 1.25610
4 cells
of the indicated strains, and total colony forming units (CFU) were
isolated from the lungs after one hour (black bars) or one week (gray
bars). The mean6maximum and minimum is shown. Panel B, survival
curve of A/Jcr mice that were similarly inoculated with 10
5 cells of wild
type (black), ada2D (red), or complemented ada2D (gray). Like those
infected with ada2D, all mice that were infected in the same study with
cap59 survived the entire period (not shown).
doi:10.1371/journal.ppat.1002411.g008
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Ste3a) showed decreased expression in the ada2D mutant. A
variety of genes that are independent of mating type but are
implicated in the pheromone response pathway were also found to
respond to loss of Ada2 (Table 1).
Our initial interest in Ada2 was stimulated by its importance in
capsule synthesis. In the ada2D mutant, we observed a reduction in
transcript abundance for a number of genes that, when deleted,
yield small capsules (Table 1). These observations are consistent
with the hypocapsular and avirulent phenotypes of the ada2D
mutant. The ada2D mutant also showed reduced expression for
genes involved in oxidative stress; this agrees with the hypersen-
sitivity to oxidative stress observed in the mutant and may also
contribute to the avirulent phenotype. Expression of two genes
(BLP1 and GAT204), which have recently been implicated in
capsule-independent mechanisms of cryptococcal virulence [24],
was also reduced in the ada2D mutant (see Discussion).
RNA-Seq Analysis Suggests New Relationships in Capsule
Regulation
To place Ada2 in the context of the broader capsule regulation
network, we performed RNA-Seq analysis on mutants that lack
the transcriptional regulators Cir1 and Nrg1. We chose these
transcription factors because, like the ada2D mutant, both the cir1D
and the nrg1D mutants are hypocapsular, demonstrate attenuated
avirulence, and exhibit defects in mating. We identified 1265
genes that were differentially expressed in the nrg1D mutant
compared to wild type under the capsule inducing condition and
Table 1. Genes downstream of Ada2 implicated in processes related to mating or virulence.
Fold change (log2)
Gene Name ada2D vs WT
Broad ID C. neo S. cer Description uninduced induced
Mating CNAG_06808 STE3 STE3 pheromone receptor Ste3 25.35 27.71
CNAG_03137 SGV1 Ste11 protein kinase 3.63 20.86
CNAG_04323 PRM10 DUF1212 family protein 20.89 20.73
CNAG_06814 SXI1 Sxi1 20.79 20.49
CNAG_04755 BCK1 Ste/Ste11 protein kinase 20.59 20.23
CNAG_03706 GLC7 phosphatase PP1 20.32 20.14
CNAG_02981 SIN3 Sin3 protein 0.47 0.46
CNAG_02375 FIG4 phosphatase 0.84 0.46
CNAG_05752 KAR3 kinesin 0.81 0.56
Capsule CNAG_03644 CAS3 Cas3 24.21 27.69
CNAG_05264 NSTA YJL216C alpha-amylase AmyA 22.06 21.97
CNAG_03438 HXT1 HXT2 hexose transporter 21.15 21.35
CNAG_02797 CPL1 pria protein 21.01 20.65
CNAG_07937 CAS1 O-acetyltransferase 20.60 20.41
CNAG_04312 MAN1 PMI40 mannose-6-phosphate isomerase 20.57 20.28
CNAG_07554 CAP10 capsule associated protein 0.43 20.15
CNAG_00124 CAS32 Cas32 20.50 0.19
CNAG_05581 CHS3 CHS3 chitin synthase 4 0.15 0.61
CNAG_05139 UGT1 Ugt1 0.36 0.73
CNAG_02138 CAS4 DNA2 DNA replication helicase dna2 0.64 1.40
Oxidation CNAG_05265 RCK1 hypothetical protein 2.28 25.91
CNAG_04415 YJR096W oxidoreductase 20.76 23.82
CNAG_05027 FMS1 amine oxidase 20.64 23.81
CNAG_04508 GRX4 conserved hypothetical protein 22.21 23.64
CNAG_03848 CNB2310-B GRX7 glutathione transferase 23.21 22.18
CNAG_03199 GRX3 oxidoreductase superfamily 20.14 21.26
CNAG_03936 PST2 cytoplasmic protein 20.71 20.74
CNAG_01005 GRX1 glutathione transferase 20.80 20.46
CNAG_00581 PEP4 endopeptidase 20.30 20.44
CNAG_02859 POS5 NADH kinase 24.08 20.13
Antiphagocytosis CNAG_06762 GAT204 GAT2 conserved hypothetical protein 21.28 21.44
CNAG_06346 BLP1 conserved hypothetical protein 22.70 20.86
Genes listed were identified by differential expression analysis of mutant versus wild type and found to be significantly changed in either capsule non-inducing or
inducing conditions. Fold change of mutant versus wild type is indicated in the rightmost columns; bold font indicates statistically significant change.
doi:10.1371/journal.ppat.1002411.t001
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mutant these values were 1257 and 529, respectively (Table S6).
Cryptococcal sexual development is regulated by Cir1 and Nrg1
[23,20], as well as by Ada2 (Figure 7). To identify common
regulatory targets shared by these three transcription factors, we
examined the gene expression data from the ada2D, cir1D, and
nrg1D mutants. Among genes previously implicated in cryptococ-
cal sexual development, we found that only SXI1a was
downstream of all three regulators, with its transcription reduced
in nrg1D and ada2D but increased in cir1D. Transcription of the
pheromone receptor STE3a was similarly reduced in ada2D and
elevated in cir1D although it was not significantly changed in
nrg1D. Genes regulated by Nrg1 included the cell type-specific
p21-activated protein kinase STE20a, as well as other mating type-
independent genes that are involved in sexual development, but
these were not regulated by Ada2 or Cir1.
By comparing mutants generated in the same strain background
and grown in the same conditions, we were able to confidently
identify capsule-implicated genes that are downstream of Cir1 or
Nrg1, some of which are also regulated by Ada2. For example,
Nrg1 and Ada2 share downstream targets that include CAS4,
CAS32, CPL1, MAN1, NSTA, and CHS3. Similarly, CAP10, CAS1,
CAS4, and CPL1 are all downstream of both Cir1 and Ada2.
Notably, CAS4 and CPL1 are shared targets of all three regulators
(Ada2, Nrg1 and Cir1).
In addition to genes that are likely to be directly involved in
capsule biosynthesis, we found many genes whose expression was
affected by the loss of Cir1 or Nrg1 that are involved in regulating
capsule formation. For example, the nrg1D mutant showed altered
transcription of genes in the cAMP pathway, including increased
transcription of RIM101 and decreased transcription of PKA2 and
PDE2. Consistent with previous reports [22], we also observed
altered transcript levels in the cir1D mutant that correspond to a
number of pH-specific pathway genes, including RIM9 and
RIM20. The latter gene product is involved in proteolytic
activation of Rim101 [21].
Finally, we discovered that Cir1 and Nrg1 regulate the
expression of two HOG pathway genes: absence of either protein
led to reduced transcription of HOG1 and increased transcription
of PBS2. Additionally, both Cir1 and Nrg1 appeared to enhance
the expression of TUP1 [46], which encodes a regulator that may
operate in the HOG pathway. Interestingly, data from a previous
microarray study indicated that ADA2 (at that time uncharacter-
ized) increased in expression upon deletion of HOG pathway
members (HOG1 or SSK1) [47] (see Discussion).
ChIP-Seq Indicates Genes Directly Regulated by
Ada2-dependent Histone Acetylation
Ada2 is required for the majority of H3K9 acetylation in C.
neoformans (Figure 5 and immunoblotting data not shown). We
reasoned that localizing Ada2-dependent occurrences of this
modification would lead us to genes that are directly regulated
by Ada2. We therefore used chromatin immunoprecipitation
(ChIP) to isolate DNA directly associated with acetylated H3K9 in
ada2D and wild type cells that we could analyze by short read
sequencing (ChIP-Seq).
We obtained 84 million short reads from our ChIP-Seq studies,
which we aligned to the serotype A reference sequence and
analyzed to identify genomic regions with statistically significant
coverage (‘‘peaks’’) in IP samples compared to input DNA. From
triplicate experiments, we identified an average of 2014 peaks in
wild type cells, compared to only 364 in ada2D. This 82%
reduction is consistent with our earlier observations on the Ada2-
dependence of most H3K9 modification (Figure 5). Consistent
with H3K9 acetylation in S. cerevisiae [48,49], the majority of the
peaks identified in wild type (75%) were within 500 bp of at least
one transcription start site (TSS) as annotated [45] (see Table S7
for a summary of TSS neighboring H3K9 acetylation for wild type
or mutant). Most peaks in wild type were also located in the 59
region immediately downstream of the TSS, with a strong
depletion near the TSS and a modest enrichment upstream of
the TSS (Figure 9, black bars in panel A). In contrast, only 28% of
peaks in ada2D were within 500 bp of a TSS and almost none of
these were downstream of the TSS (Figure 9, red bars in panel A).
Thus, not only is histone acetylation in this mutant depleted
throughout the genome, the pattern of acetylation is also changed,
with the most dramatic depletion occurring in the region
immediately downstream of the transcription start site.
The loss of histone acetylation in ada2D cells suggested Ada2-
dependent transcriptional activation at specific loci (see example in
Figure 9, panel B). We anticipated that some of these genes would
also show reduced transcription by RNA-Seq in the ada2D mutant;
this was indeed the case (p , 0.003). In contrast, we found no such
relationship for genes with increased transcription in ada2D (i.e.,
genes that are directly or indirectly repressed by Ada2; p . 0.99),
consistent with the generally activating function of the SAGA
complex. Overall, we found that genes differentially expressed in
the ada2D deletion strain that also lost histone acetylation near the
TSS were twice as likely to exhibit reduced transcriptional
abundance as genes that did not lose histone acetylation (Figure
S1).
We were particularly interested in genes that were activated by
Ada2 according to our RNA-Seq analysis and also showed Ada2
dependent H3K9 acetylation in our ChIP-seq analysis. This set is
significantly enriched for genes that are directly regulated by
Gat201 (p , 0.0001), including BLP1 and GAT204 [24]. The
genes implicated by both RNA-seq and ChIP-seq also include a
number with known capsule phenotypes, such as CPL1, HXT1,
STE3a, and UGT1 (see Discussion).
Discussion
We analyzed gene expression in C. neoformans yeast cells cultured
over a diverse set of growth conditions that stimulate capsule
production to varying degrees and identified a transcriptional
signature of capsule formation. Gene ontology (GO) analysis
shows that this signature is enriched for genes involved in stress
response, as expected from the conditions we used to induce
capsule formation. The signature also contains a significant
number of genes that have previously been implicated in capsule
regulation; the expression of most of these correlates with capsule
in a manner consistent with the null phenotype. The phosphodi-
esterases Pde1 and Pde2 are exceptions to this pattern: their
transcript levels correlated positively with capsule size, while their
disruption increases capsule size [34]. Pde1 and Pde2 hydrolyze
cAMP to AMP and thereby inhibit the cAMP-dependent
activation of regulators known to stimulate capsule formation.
Elevated levels of cAMP occurring under capsule inducing
conditions may lead to elevated transcription of PDE1 and
PDE2, which would ultimately attenuate the cAMP signal.
Feedback inhibition of cAMP signaling via post-translational
activation of phosphodiesterases has been documented in both S.
cerevisiae and C. neoformans [50,34].
One sequence in the transcriptional signature that correlated
significantly with capsule size (Figure 2) encoded the putative
transcriptional regulator, Ada2. This protein has been character-
ized most extensively for its role within the SAGA complex, which
broadly regulates the transcription of genes involved in stress
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pattern holds true for C. neoformans, based on the increased
sensitivity of mutants that lack either ADA2 (this work) or GCN5
[31] to reactive oxygen species, ethanol, alkaline pH, elevated
temperature, and CaCl2 (Figure 6). All of these sensitivities are
shared by S. cerevisiae SAGA mutants [42,51], and the last two also
are shared by SAGA mutants in other fungi including C. albicans,
S. pombe and S. kluyveri [40,42].
Despite many conserved functions of the SAGA complex across
fungal species, several phenotypes of ada2 mutants in C. neoformans
differ markedly from those observed in other fungi, perhaps
reflecting the specific evolutionary pressures of the cryptococcal
niche. Whereas ada2 mutants in C. neoformans display increased
caffeine resistance (Figure 6), for example, disruption of SAGA
components in S. cerevisiae, S. pombe and S. kluyveri has the opposite
effect. Also, ada2 mutants in C. neoformans show an increase in LiCl
resistance but no change in KCl resistance (Figure 6), while other
fungi defective in SAGA typically exhibit normal growth in LiCl
but are KCl sensitive relative to wild type [42]. Interestingly, ada2
mutants in C. neoformans have wild type sensitivity to fluconazole in
contrast to ada2 mutants in C. albicans, which have increased
sensitivity [40]. Finally, C. neoformans ada2D differs from other fungi
in its regulation of sexual development. In S. pombe, the ada2D
mutant is enhanced for mating, probably through a mechanism
that does not directly involve histone acetylation [52]. In the C.
neoformans ada2D strain, we instead found dramatically decreased
sexual development (Figure 7), reduced transcript abundance of
the pheromone receptor STE3a, and loss of H3K9 acetylation at
the STE3a promoter. These results suggest that these two fungi
differ in both the direction and the mechanism of Ada2’s influence
on sexual development.
Recently, another component of the SAGA complex, Gcn5, was
shown to play a role in capsule formation and virulence in C.
neoformans [31]. H99 cells lacking Gcn5, like our mutant lacking
Ada2, are hypocapsular and hypovirulent. To compare the roles of
these proteins, we examined genes that are differentially expressed
by ada2D and gcn5D upon growth in DMEM, using our RNA-Seq
data for ada2D (Table S4) and published microarray data sets for
gcn5D [31]. We found a significant overlap in the sets of genes
whose expression is affected by each mutation (p , 1e-5),
supporting the idea that some genes are jointly regulated by
Gcn5 and Ada2, probably due to the coordinated role of these
proteins in SAGA-mediated histone acetylation.
In addition to shared characteristics, we observed important
differences between the ada2D and gcn5D mutants at both the
phenotypic and transcriptional levels. The ada2D mutant is more
resistant to high temperature, showing ,10-fold growth inhibition
on rich medium at 39uC compared to wild type (Figure 6), a
condition where gcn5D does not grow at all [31]. In contrast, ada2D
is more sensitive than gcn5D to the calcineurin inhibitor FK506.
(The minimal inhibitory concentration (MIC) for gcn5D is 10-fold
below that of its H99 parent [31], while the MIC for ada2D
(performed as in [31]) is at least 67-fold below that of KN99a; data
not shown.). We also found that expression of both STE3a and
SXI1a responds to the loss of Ada2 (Table 1), whereas no sexual
development genes have been reported to be downstream of Gcn5
[31]. Consistent with this difference, ada2D is severely defective in
filamentation (Figure 7) while gcn5D filaments normally (T. R.
O’Meara and J. A. Alspaugh, personal communication). Further-
more, two genes involved in the recently described ‘antiphagocytic
response’ [24], GAT204 and BLP1, showed a loss of both H3K9
acetylation (Figure 9, panel B and Table S7) and expression
(Table 1) in ada2D but no change in expression in gcn5D [31]. It
will be interesting to determine whether these transcriptional
differences manifest phenotypically.
The phenotypic differences between ada2D and gcn5D may be
due to Gcn5-independent functions of Ada2 in C. neoformans.
Acetylation at some loci may rely on Ada2 partnering with a
histone acetyltransferase (HAT) other than Gcn5, or it may be that
the regulation of these loci is independent of acetylation altogether.
Figure 9. Ada2-dependent acetylation of H3K9 is enriched near
gene transcription start sites. ChIP-Seq was performed on wild type
(WT) and the ada2D mutant to identify genes located in the proximity
of acetylated H3K9. Panel A, a histogram of peaks that occur within
500 bp of the transcription start site of all identified genes [45]. Panel B,
an example of ChIP-Seq data aligned to a gene model of GAT204, which
was identified as Ada2-dependent by both ChIP-Seq and RNA-Seq. The
y-axis represents normalized coverage (reads per million mapped) for
samples defined in the text. Coverage is shown for 2 standard
deviations above the mean input sample coverage and above. Note
that the input DNA profiles are similar for WT and mutant cells, while
specific H3K9 associated sequences show TSS-associated peaks only in
the WT.
doi:10.1371/journal.ppat.1002411.g009
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preventing the spread of repressive chromatin [53]. Such
mechanisms remain to be investigated in C. neoformans. Given the
importance of SAGA in virulence, the roles of Ada2, Gcn5 and
other SAGA subunits in C. neoformans biology are worthy of further
investigation.
After identifying Ada2 as a novel regulator of capsule, we sought
to identify elements downstream of it in the capsule regulatory
network. To do this, we performed RNA-Seq on the ada2D mutant
and wild type strains, considering genes differentially expressed
between these two strains to be downstream of Ada2. To identify
probable direct targets of Ada2, we performed ChIP-Seq using
antibodies specific for H3K9 acetylation, comparing the ada2D
mutant and wild type strains. We reasoned that genes that lose
histone acetylation near their transcription start sites in the ada2D
mutant are likely direct targets of Ada2 via the SAGA complex or
another histone acetyltransferase (HAT) complex involving Ada2.
The ada2D mutant strain revealed a dramatically altered
landscape of H3K9 acetylation compared to the wild type, with
more than an 80% reduction in acetylated sites across the genome
(see Results) and even greater reduction around transcription start
sites (Figure 9). This nearly total loss of H3K9 acetylation in the
ada2D mutant is consistent with the established global HAT
activity of SAGA in S. cerevisiae [54,55]. In contrast to its broad
histone modification activity, SAGA only influences expression of
10% of S. cerevisiae genes [39]. RNA-Seq analysis of the ada2D
mutant strain revealed that Ada2 influences transcription of 14%
of the genes in C. neoformans, indicating that the transcriptional
regulatory role of SAGA in C. neoformans is also locus specific.
ChIP-Seq data further suggest that Ada2 exerts the minority of its
influence through direct regulation: only 3% of cryptococcal genes
exhibit both altered H3K9 acetylation and expression in ada2D
cells, while 11% exhibit altered expression only. This large indirect
response could be mediated in part via the 8 putative transcription
factors that Ada2 directly regulates as evidenced by our studies.
Consistent with the activating role of SAGA, the set of genes
with reduced expression in ada2D was significantly enriched for
those that lost H3K9 acetylation. (In contrast, genes with increased
expression in ada2D showed no significant overlap with those that
lost H3K9 acetylation.) Some genes, including the capsule-
implicated gene UGT1, showed increased expression together
with loss of H3K9 acetylation in the ada2D mutant, perhaps
because H3K9 acetylation at certain loci makes repressor binding
sites more accessible. Alternatively, these genes may be directly
activated by Ada2 through H3K9 acetylation yet also indirectly
repressed by Ada2, which could yield net repression.
We observed phenotypic changes in the ada2D mutant in sexual
development, capsule formation, stress response, and virulence; we
also found genes with known roles in these processes to be directly
regulated by Ada2 as evidenced by ChIP-Seq and RNA-Seq. For
example, we found that Ada2 directly regulates genes encoding
proteins implicated in capsule formation, including HXT1 [56],
CPL1 [25], and UGT1 [57], consistent with the capsule defect of
the ada2D mutant (Figure 3). We also identified the gene encoding
pheromone receptor Ste3 as a direct target of Ada2 in the mating
type a (MATa) cells used in these studies, consistent with the
observed filamentation defect in ada2D (Figure 7). Ste3 has also
been implicated in mating in MATa [28]. Ste3a has further been
shown to regulate virulence factors including titan cell [8] and
capsule formation [28], although no such relation has been
reported for Ste3a. If Ada2 also regulates Ste3a then it may
additionally influence capsule via this pathway in MATa cells.
Future studies of MATa ada2D mutants will be needed to address
this possibility.
Gat201 is a GATA family transcription factor reported to act as
a positive regulator of capsule [25]. Interestingly, we observe a
significant overlap in the genes that are directly activated by Ada2
(as shown by ChIP-Seq) and those that are direct targets of Gat201
(by ChIP-chip [24]), including the antiphagocytic genes BLP1 and
GAT204. Since the SAGA complex typically works in concert with
other transcription factors, this suggests that Ada2 may work with
Gat201 to activate transcription. It may be that Gat201 recruits
Ada2 in the context of SAGA for these purposes. Alternatively,
another factor may recruit the SAGA complex, which then
enables Gat201 to bind.
To explore the interplay between regulatory pathways we
considered two transcription factors, Cir1 [23] and Nrg1 [20],
which like Ada2 enhance both capsule and mating responses. In
the set of genes regulated by Cir1 and Nrg1 (Table S5 and Table
S6), we identified two that encode proteins in the HOG pathway,
Hog1 and Pbs2; both Cir1 and Nrg1 transcriptionally repress
Pbs2 and activate Hog1. Cells lacking either Pbs2 or Hog1 show
increased capsule formation and sexual development [26].
Furthermore, both ADA2 and GCN5 were shown in earlier work
to be transcriptionally repressed by Hog1 under nutrient rich
conditions [47]. This observation, in conjunction with our data,
suggests that the HOG pathway may regulate capsule and mating
via Ada2 (Figure 10). Our transcriptional analysis suggests that
Nrg1 and Cir1 operate on the HOG pathway through a shared
incoherent feed-forward loop, by transcriptionally activating
Hog1 and simultaneously repressing Pbs2. In nutrient rich
conditions, Hog1 is constitutively phosphorylated by Pbs2 and
represses mating and capsule. The logic of this circuit implies that
in capsule inducing conditions Cir1 and Nrg1 repress transcrip-
tion of PBS2; this leads to reduced levels of phosphorylated Hog1,
thus derepressing ADA2 transcription and enhancing capsule
formation. Simultaneously transcription of HOG1 is increased,
leading to an even greater abundance of unphosphorylated Hog1.
This increase in Pbs2 substrate may allow rapid restoration of the
transcriptional repression of Ada2 once the environmental cues
for capsule induction are no longer present. Although transcript
levels of ADA2 were not significantly altered in the nrg1D and
cir1D mutants at the 90-minute time point that we tested, ADA2
expression may be affected by these mutations at later time
points. Future studies will also be needed to determine whether
the influences of Cir1 and Nrg1 on PBS2 and HOG1 result from
direct or indirect regulation, and to better characterize the exact
structure and function of this hypothesized regulatory circuit.
This model, rich in testable hypotheses, illustrates the power of
combining RNA-Seq and ChIP-Seq data in an integrated
analysis.
Our identification of Ada2 in the capsule transcriptional
network validates our strategy for probing capsule regulation
and suggests that it may be valuable in studying the regulation of
other processes that are important in microbial pathogenesis.
These studies also lead in numerous exciting directions for the
future. Our parallel comparison of multiple mutants in the same
strain background and growth conditions has allowed us to
identify previously unobserved relationships among capsule
regulators, which we look forward to testing. Our analysis of the
transcriptional signature of capsule induction also suggests
multiple potential transcription factors that can be pursued to
further probe the complex confluence of pathways that lead to
capsule synthesis, and our implementation of ChIP-Seq in C.
neoformans demonstrates a high-resolution way for differentiating
direct from indirect regulatory relationships. Overall, our work
highlights the power of integrative transcriptome analysis to dissect
regulatory networks in C. neoformans and beyond.
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Ethics Statement
All animal studies were reviewed and approved by the Animal
Studies Committee of Washington University School of Medicine
and conducted according to the National Institutes of Health
guidelines for housing and care of laboratory animals.
Materials
All chemicals were from Sigma, primers were from Invitrogen,
and restriction enzymes were from New England Biolabs unless
otherwise noted. All kits and enzymes were used according to
manufacturer recommendations unless otherwise specified.
Strains and Growth Conditions
All strains used in this study are capsule serotype A, which
causes the majority of illness in immunocompromised patients
[58], and are listed in Table S3. Microarray experiments to
identify the transcriptional signature of capsule were performed
with C. neoformans H99 and mutants were constructed in C.
neoformans KN99. All cells were grown with continuous shaking
(230 rpm) at 30uC in YPD medium (1% w/v yeast extract, 2% w/
v peptone, 2% w/v glucose), or at 30uC on agar plates (YPD
medium with 2% w/v agar). As appropriate, media were
supplemented with either 100 mg/ml of nourseothricin (from
Werner BioAgents) or 100 mg/ml of Geneticin (G418; from
Invitrogen). Genetic crosses were performed at room temperature
(RT) in the dark on V8 agar plates (5% v/v V8 juice, 0.05% w/v
KH2PO4 pH 5, 4% w/v agar) as described [37]. To induce
expression of genes involved in capsule formation, cells cultured
overnight in YPD were collected by centrifugation, washed in
DMEM, and adjusted to 4 6 10
7 cells/ml in DMEM. This cell
suspension was first incubated at 30uC in room air for 2 hr, then
shifted to 37uC with 5% CO2 for 1.5 hr. Conditions used for
phenotypic testing of mutants are detailed in Text S1.
RNA Isolation
Approximately 2 6 10
8 cells were collected by centrifugation,
suspended in TRIzol reagent (from Invitrogen), and subjected to
mechanical lysis by bead beating at 4uC with 0.5-mm glass beads
for 1 min, followed by a 2-min rest, for a total of 5 cycles.
Following lysis, total RNA was extracted according to the
manufacturer’s instructions. Residual DNA was removed from
the RNA preparation by treatment with the Turbo DNA-free kit
(from Ambion) according to the manufacturer’s instructions.
Microarray Experiments
H99 cells were cultured overnight at 37uC in the following eight
conditions: low iron medium with or without both 500 mM
ethylenediaminetetraacetic acid (EDTA) and 10 mM bathophe-
nanthroline disulfonate (BPDS); phosphate-buffered saline (PBS)
with or without 10% v/v fetal bovine serum; Dulbecco’s Modified
Eagle’s Medium (from Sigma) in room air or 5% CO2; and
Littman’s medium [13] with either 0.01 mg/ml or 1 mg/ml
thiamine. All experiments were performed in triplicate. Total
RNA was isolated from each culture and hybridized to a C.
neoformans serotype A/D microarray against a shared reference
pool of RNA as described [59]. Slides were scanned on a Perkin-
Elmer ScanArray Express HT scanner to measure Cy3 and Cy5
fluorescence as described [59]. Normalization of the raw spot
intensities was performed using LIMMA [60]. Normalization was
performed using normexp with an offset of 50 followed by Loess
and values for replicate probes on the array were averaged to
represent expression of the associated gene. The correlation
between gene expression and capsule radius (which was measured
for each sample at the time of RNA isolation) was assessed using
SAM [61] and statistical significance was calculated using a false
discovery threshold of 5%. A hypergeometric test was applied to
determine the enrichment of capsule-implicated genes (genes
whose mutation yields an alteration in capsule size or morphology;
Table S1) in the positively and negatively correlating sets of genes.
The complete array data set is available at GEO accession number
GSE31911.
Strain Construction
The C. neoformans H99 reference sequence was accessed through
the Fungal Genome Initiative database at the Broad Institute of
MIT and Harvard available at ,http://www.broadinstitute.org/
science/projects/projects.. Cryptococcal genomic DNA was
isolated as described [62] and a split-marker approach [63] was
used to replace each genomic coding sequence of interest with a
nourseothricin resistance marker (NAT) by homologous recombi-
nation. Each mutant was also labeled with a unique signature tag
Figure 10. A model of Ada2 within the broader network of
capsule, mating, and antiphagocytic responses (see text for
details). Links from Cir1 and Nrg1 are supported by RNA-Seq data
presented here. Links from Hog1 and Pbs2 are supported by published
microarray data [47]; links from Gat201 are supported by published data
from microarrays and ChIP-chip [24]; and links from Ada2 are supported
by RNA-Seq and ChIP-chip data presented here. Red ovals, transcription
factors; blue rounded rectangles, signaling proteins; green rounded
rectangles, other proteins; green lines, stimulation of transcription; red
lines, inhibition of transcription; solid black arrow, phosphorylation; P,
phosphate; dashed arrow, catalysis by Pbs2.
doi:10.1371/journal.ppat.1002411.g010
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bp priming site (59 - AGAGACCTCGTGGACATC - 39)
immediately downstream of NAT. We also used the split-marker
gene replacement approach to introduce a single copy of the
hemagglutinin (HA) epitope-tag sequence at the 39 end of the
ADA2 genomic coding sequence. Details of strain construction are
provided in Text S1, Table S9 and Table S10.
Capsule Induction and Quantitation of Capsule Size
Cells cultured in YPD were washed extensively in DMEM, then
adjusted to 10
6 cells/ml in DMEM and incubated for 24 hours at
37uC with 5% CO2. Capsules were visualized by negative staining
with India ink, and a minimum of 100 randomly chosen cells were
imaged with identical acquisition settings on a Zeiss Axioskop 2
MOT Plus wide-field fluorescence microscope. Capsule radius was
calculated as half the difference between the capsule diameter and
the diameter of the cell body.
Immunofluorescence Microscopy
Cells were cultured overnight in YPD, and the expression of
genes involved in capsule formation was induced as described
above. Cells were then collected by centrifugation, washed in PBS,
adjusted to 3 610
8 cells/ml in 4% w/v formaldehyde buffered in
PBS, and incubated for 1 hr with rotation. Fixed cells were
collected by centrifugation (1 min, 4006g), washed extensively in
PBS, adjusted to 3 610
8 cells/ml in Lysis Buffer (50 mM sodium
citrate pH 6.0, 1 M sorbitol, 35 mM b-mercaptoethanol) plus
25 mg/ml Lysing Enzymes (from Trichoderma harzianum), and
incubated for 1 hr at 30uC. Digested cells were collected by
centrifugation (3 min, 400 6g), washed with HS Buffer (100 mM
HEPES pH 7.5, 1 M sorbitol), and resuspended in 100-200 mlo f
HS Buffer. The cell suspension was spotted in 20-ml aliquots on a
glass microscope slide coated with 0.1% w/v poly-L-lysine and
incubated for 20 min at RT.
All subsequent treatments and washes were performed by the
application of 20-ml volumes and incubation at RT, and were
followed by aspiration. The slides were first treated with HS
Buffer containing 1% v/v Triton X-100 and incubated for
10 min; they were then washed with PBS and treated with
Blocking Buffer (5% v/v goat serum, 0.02% v/v Tween-20 in
PBS) for 1 hr. Cells were next labeled with either a high-affinity
rat anti-HA monoclonal antibody (0.2 mg/ml in Blocking
Buffer; from Roche), a rabbit anti-acetyl-Histone H3 polyclonal
antibody (0.5 mg/ml in Blocking Buffer; from Millipore), a
rabbit anti-acetyl-Histone H4 polyclonal antibody (1 mg/ml in
Blocking Buffer; from Millipore), or Blocking Buffer alone
overnight in a moist chamber at 4uC. Cells were then washed
with Blocking Buffer, and treated for 1 hr in the dark with
either Alexa Fluor 594 goat anti-rat IgG or Alexa Fluor 594
goat anti-rabbit IgG (2 mg/ml in Blocking Buffer; from
Invitrogen). Next, cells were again washed with Blocking
Buffer, counterstained with 49,6-diamidino-2-phenylindole
(DAPI; 5 mg/ml in PBS) for 20 min in the dark, washed with
PBS, allowed to air-dry, and mounted in Prolong Gold (from
Invitrogen). Brightfield and fluorescence images were acquired
simultaneously on a Zeiss Axioskop 2 MOT Plus wide-field
fluorescence microscope. All samples were imaged with
identical acquisition settings.
Growth and Virulence in Mice
Two types of animal studies were performed, both in
compliance with all institutional guidelines for animal experimen-
tation. For a short term model of fungal survival in the mouse
lung, strains to be tested were cultured overnight in YPD medium,
collected by centrifugation, washed in PBS, and diluted to 2.5 6
10
5 cells/ml in PBS. For each strain, eight 4–6 week-old female
C57Bl/6 mice (from Jackson Laboratories) were anesthetized with
a combination of ketaset-HCl and xylazine, and inoculated
intranasally with 50 ml of the prepared yeast suspension. Three
animals from each cohort were sacrificed at 1 hr post-inoculation;
the remaining five were sacrificed after 7 days. Lungs were
harvested following sacrifice, and homogenized in PBS. Serial
dilutions of the homogenate were plated on YPD agar for
determination of colony-forming units (CFU). Initial inocula were
also plated to confirm CFU.
To assess longer-term affects of cryptococcal infection, each
strain was cultured and prepared as above, with the exception that
the cells were diluted to 2 610
6 cells/ml in PBS. Ten 4–6 week-
old female A/Jcr mice (from the National Cancer Institute) were
anesthetized as described above and inoculated intranasally with
100 ml of the prepared cell suspension. The animals were weighed
within 1 hr post-inoculation, and subsequently on every other day.
Mice were sacrificed if weight decreased to a value less than 80%
of peak weight (an outcome which in this protocol precedes any
signs of disease) or upon completion of the study. Initial inocula
were plated to confirm CFUs.
RNA-Seq
Cells were cultured overnight in YPD, and grown for 90
minutes in either capsule-inducing (DMEM, 37uC, 5% CO2)o r
capsule non-inducing (DMEM, 30uC, room air) conditions prior
to isolation of total RNA. A minimum of two biological
replicates were performed for each mutant (ada2D, nrg1D and
cir1D) and four for wild type. PolyA+ RNA was purified from
total RNA using the Dynabeads mRNA Purification Kit
according to the manufacturer’s instructions (from Invitrogen).
Each sample was resuspended in 2 ml of 100 mM zinc acetate
a n dh e a t e da t6 0 uC for 3 minutes to fragment the RNA by
hydrolysis. The reaction was quenched by the addition of 2 ml
volumes of 200 mM EDTA and purified with an Illustra
Microspin G25 column (from GE Healthcare). First strand
cDNA was made using hexameric random primers and
SuperScript III Reverse Transcriptase (from Invitrogen) ac-
cording to the manufacturer recommendations, and the product
was treated with E. coli D N Al i g a s e ,D N Ap o l y m e r a s eI ,a n d
RNase H to prepare double stranded cDNA using standard
methods. The cDNA libraries were end-repaired with a Quick
Blunting kit (from New England BioLabs) and A-tailed using
Klenow exo- and dATP. Illumina adapters with four base
barcodes were ligated to the cDNA and fragments ranging from
150-250 bp in size were selected using gel electrophoresis as
recommended by the manufacturer. The libraries were enriched
in a 10-cycle PCR with Phusion Hot Start II High-Fidelity DNA
Polymerase (from Finnzymes Reagents) and pooled in equimo-
lar ratios for multiplex sequencing. Single read, 36-cycle runs
were completed on the Illumina Genome Analyzer IIx.
Sequenced reads were aligned to the C. neoformans H99 reference
sequence [45] using Tophat [64]. Reads that aligned uniquely to
the reference sequence were considered for gene expression
quantification with Cufflinks [65] using the current genome
annotation provided by the Broad institute. Gene expression was
normalized using the Cufflinks provided option for quartile
normalization. Differential expression analysis comparing mutant
to wild type was performed with LIMMA [60] and ELNN [66]
using a 5% false discovery rate. Genes whose expression was found
to be significantly changed by either analysis method were counted
as differentially expressed. RNA-Seq data is available at GEO
accession number GSE32049.
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GO enrichment analysis was performed by assigning GO
categories to each gene according to the Broad Institute’s PFAM
annotations using the mapping provided by the Gene Ontology
project (http://www.geneontology.org/external2go/pfam2go). A
hypergeometric test was applied for each GO category, the
resulting p-values were corrected for multiple hypothesis testing,
and a cutoff of 0.05 was used to determine significance.
Chromatin Immunoprecipitation (ChIP)
Wild type and ada2D cells were cultured in triplicate overnight
in YPD, and grown in capsule-inducing conditions (DMEM, 37
uC, 5% CO2) for 90 minutes. Cells were then fixed for 5 min in
1% (v/v) formaldehyde, and the reaction quenched with a final
concentration of 125 mM glycine. Fixed cells were collected by
centrifugation, washed with PBS, and resuspended in Buffer A
(50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% v/v
Triton X-100, 0.1% w/v sodium deoxycholate) supplemented
with protease inhibitors and 20 mM sodium butyrate (a histone
deacetylase inhibitor). The cell suspension was subjected to
mechanical bead-beating with 0.5-mm zirconium silicate beads
for 2 min at 4uC, followed by a 2-min rest, for a total of 10 cycles.
Chromatin was then sheared by sonicating the lysate for 30 sec at
40% power output, followed by a 1-min rest on ice, for a total of
40 cycles, and the lysate clarified by centrifugation. A fraction of
the sheared chromatin was reserved as an input sample and the
remainder was used for immunoprecipitation. Acetylated histone
H3 was immunoprecipitated overnight with anti-acetyl-H3 (K9)
antibody (from Millipore) tethered to protein-A sepharose (10 ml
in a total volume of 700 ml). The beads were next washed
sequentially in Buffer A, Buffer B (50 mM HEPES pH 7.5,
500 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 0.1% (w/
v) sodium deoxycholate), Buffer C (10 mM Tris-HCl pH 8.0,
250 mM LiCl, 1 mM EDTA, 0.5% (v/v) NP-40, 0.5% w/v
sodium deoxycholate), and Buffer D (10 mM Tris, 1 mM EDTA),
and immunoprecipitated protein was eluted with Buffer E (50 mM
Tris pH 8.0, 10 mM EDTA, 1% (w/v) SDS). Crosslinked DNA
from input and IP samples was released by incubating the eluate at
65uC overnight, and extracted with a solution of phenol/
chloroform/isoamyl alcohol (25:24:1) prior to ethanol precipita-
tion and resuspension in water. Mock IP reactions with no
antibody yielded no measurable product (not shown) and were not
quantified further.
ChIP-DNA for input and IP samples was end-repaired with
Klenow DNA Polymerase and the DNA was purified with
AMPure XP System beads (Beckman Coulter Genomics) and
modified with A-tails using Klenow exo- before ligation to
adapters to incorporate 7-base index sequences using T4 DNA
ligase (Enzymatics). Adapter addition was confirmed on an Agilent
2100 bioanalyzer, and the DNA was PCR-amplified and then gel
purified to remove adapter dimers and select sizes optimal for
high-throughput sequencing (150 to 300 bp). Libraries were 12-
way multiplexed on an individual lane of an Illumina Hi-Seq 2000
flow cell, resulting in approximately 7 million 42-bp single ended
reads per sample.
Reads generated from the input and IP samples were aligned to
the C. neoformans serotype A reference sequence [45] using Bowtie
[67]. Reads that mapped to multiple genomic loci were discarded.
Peak calling was performed using MACS [68] with a significance
threshold of 1 6 10
-10. To assess gross differences between the
mutant and wild type, the average number of peaks over the three
biological replicates of each strain was compared. Peaks were
associated with specific genes if the peak center fell within 500 bp
of the gene transcription start site according to the current
annotation by the Broad Institute [45]. (For genes with
unannotated 59-UTRs this may correspond to the translation
start site.) Ada2-dependent peak loss was identified by cases where
a gene in two of the three wild type biological replicates possessed
a neighboring peak and no peak was found to neighbor the gene in
any of the three ada2D mutant replicates. ChIP-Seq data is
available at GEO accession number GSE32075.
Supporting Information
Figure S1 Ada2-dependent loss of H3-K9 acetylation is
associated with activation. The ratio of Ada2 activated to Ada2
repressed genes (y-axis) is determined by an analysis of differential
gene expression from RNA-Seq data comparing ada2D and wild
type strains. The cutoff to be counted as differentially expressed is
varied from 0 fold to ,12 fold (x-axis). Ada2 activated genes
exhibit a negative fold change greater than the cutoff and Ada2
repressed genes exhibit a positive fold change greater than the
cutoff. Genes that lose neighboring H3-K9 acetylation near their
TSS in the ada2D mutant are shown in red, genes that shown
unchanged H3-K9 acetylation are shown in black.
(TIFF)
Table S1 Capsule-implicated genes. Genes for which the
corresponding mutant strain has been shown to yield cells with
altered capsule size or morphology.
(XLS)
Table S2 The transcriptional signature of capsule. Genes found
to be significantly correlated with capsule size over panel of in vitro
conditions are ordered by significance according to estimated false
discovery rate (FDR).
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Table S3 C. neoformans strains used in this study.
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Table S4 Genes differentially expressed in the ada2D mutant.
Genes found to be differentially expressed by RNA-Seq comparing
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non-inducing conditions (see Methods).
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Table S5 Genes differentially expressed in the nrg1D mutant.
Genes included are those found to be differentially expressed by
RNA-Seq comparing wild type to nrg1D mutant strains in either
capsule inducing or non-inducing conditions (see Methods).
(XLS)
Table S6 Genes differentially expressed in the cir1D mutant.
Genes included are those found to be differentially expressed by
RNA-Seq comparing wild type to cir1D mutant strains in either
capsule inducing or non-inducing conditions (see Methods).
(XLS)
Table S7 Genes with neighboring histone acetylation peaks.
Genes included are those with H3-K9 acetylation peaks within
500 bp of their transcription start site as currently annotated (see
Methods). The number of biological replicates that support a
neighboring peak is indicated for wild type and ada2D mutant
strains.
(XLS)
Table S8 Primers used for constructing the mutant strains.
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Table S9 Primers used to generate the ADA2 reconstituted
strain.
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